|
[1]
|
Analysis of CK5/6 and EGFR and Its Effect on Prognosis of Triple Negative Breast Cancer
Frontiers in Oncology,
2021
DOI:10.3389/fonc.2020.575317
|
|
|
|
|
[2]
|
Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
Journal of Oncology,
2020
DOI:10.1155/2020/4061063
|
|
|
|
|
[3]
|
Molecular characteristics of breast cancer according to clinicopathological factors
Molecular and Clinical Oncology,
2019
DOI:10.3892/mco.2019.1869
|
|
|
|
|
[4]
|
Prognostic impact of EGFR and cytokeratin 5/6 immunohistochemical expression in triple-negative breast cancer
Annals of Diagnostic Pathology,
2017
DOI:10.1016/j.anndiagpath.2017.01.009
|
|
|
|
|
[5]
|
Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers
PLOS ONE,
2016
DOI:10.1371/journal.pone.0149661
|
|
|
|
|
[6]
|
Clinicopathological Characteristics of Triple Negative Breast Cancer at a Tertiary Care Hospital in India
Asian Pacific Journal of Cancer Prevention,
2015
DOI:10.7314/APJCP.2014.15.24.10577
|
|
|
|
|
[7]
|
Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET/CT imaging
Breast Cancer Research and Treatment,
2015
DOI:10.1007/s10549-015-3558-1
|
|
|
|
|
[8]
|
Correlation of CK5 and EGFR with Clinicopathological Profile of Triple-Negative Breast Cancer
Pathology Research International,
2014
DOI:10.1155/2014/141864
|
|
|
|